Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael T Dill

Showing results (21-30 of 47) with videos related to

Pageof 5
Sort By:
Journal of Hepatology|December 1, 2012
Impact of genetic SLC28 transporter and ITPA variants on ribavirin serum level, hemoglobin drop and therapeutic response in patients with HCV infectionMonika Rau, Felix Stickel, Stefan Russmann, et al.
Clinics and Research in Hepatology and Gastroenterology|March 19, 2021
HBV-infection rate and long-term outcome after liver-transplantation of anti-HBc-positive liver-grafts to HBV-naïve recipients: A retrospective studyDaniel Hornuss, Anna Rudi, Lucas Koerner, et al.
Journal of Cancer Research and Clinical Oncology|February 4, 2021
Treatment stage migration and treatment sequences in patients with hepatocellular carcinoma: drawbacks and opportunitiesCyrill Wehling, Michael T Dill, Alexander Olkus, et al.
Hepatology (Baltimore, Md.)|August 10, 2013
Quantitative proteomics identifies the membrane-associated peroxidase GPx8 as a cellular substrate of the hepatitis C virus NS3-4A proteaseKenichi Morikawa, Jérôme Gouttenoire, Céline Hernandez, et al.
The Journal of Clinical Investigation|February 27, 2014
Pegylated IFN-α regulates hepatic gene expression through transient Jak/STAT activationMichael T Dill, Zuzanna Makowska, Gaia Trincucci, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|December 24, 2014
An intrahepatic transcriptional signature of enhanced immune activity predicts response to peginterferon in chronic hepatitis BLouis Jansen, Annikki de Niet, Zuzanna Makowska, et al.
Cell Stem Cell|July 31, 2020
Regenerative Reprogramming of the Intestinal Stem Cell State via Hippo Signaling Suppresses Metastatic Colorectal CancerPriscilla Cheung, Jordi Xiol, Michael T Dill, et al.
Targeted Oncology|February 28, 2024
Durvalumab Plus Gemcitabine and Cisplatin in Patients with Advanced Biliary Tract Cancer: An Exploratory Analysis of Real-World DataAlexander Olkus, Aurelie Tomczak, Anne Katrin Berger, et al.
Radiation Oncology (London, England)|February 19, 2025
Stereotactic body radiotherapy with carbon ions as local ablative treatment in patients with primary liver cancerPaula Hoffmeister-Wittmann, Philipp Hoegen-Saßmannshausen, Livia Wicklein, et al.
Cell Stem Cell|May 14, 2019
Single-Cell Analysis of the Liver Epithelium Reveals Dynamic Heterogeneity and an Essential Role for YAP in Homeostasis and RegenerationBrian J Pepe-Mooney, Michael T Dill, Anna Alemany, et al.
Pageof 5

Showing results (21-30 of 47) with videos related to

Sort By:
Pageof 5
Journal of Hepatology|December 1, 2012
Impact of genetic SLC28 transporter and ITPA variants on ribavirin serum level, hemoglobin drop and therapeutic response in patients with HCV infectionMonika Rau, Felix Stickel, Stefan Russmann, et al.
Clinics and Research in Hepatology and Gastroenterology|March 19, 2021
HBV-infection rate and long-term outcome after liver-transplantation of anti-HBc-positive liver-grafts to HBV-naïve recipients: A retrospective studyDaniel Hornuss, Anna Rudi, Lucas Koerner, et al.
Journal of Cancer Research and Clinical Oncology|February 4, 2021
Treatment stage migration and treatment sequences in patients with hepatocellular carcinoma: drawbacks and opportunitiesCyrill Wehling, Michael T Dill, Alexander Olkus, et al.
Hepatology (Baltimore, Md.)|August 10, 2013
Quantitative proteomics identifies the membrane-associated peroxidase GPx8 as a cellular substrate of the hepatitis C virus NS3-4A proteaseKenichi Morikawa, Jérôme Gouttenoire, Céline Hernandez, et al.
The Journal of Clinical Investigation|February 27, 2014
Pegylated IFN-α regulates hepatic gene expression through transient Jak/STAT activationMichael T Dill, Zuzanna Makowska, Gaia Trincucci, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|December 24, 2014
An intrahepatic transcriptional signature of enhanced immune activity predicts response to peginterferon in chronic hepatitis BLouis Jansen, Annikki de Niet, Zuzanna Makowska, et al.
Cell Stem Cell|July 31, 2020
Regenerative Reprogramming of the Intestinal Stem Cell State via Hippo Signaling Suppresses Metastatic Colorectal CancerPriscilla Cheung, Jordi Xiol, Michael T Dill, et al.
Targeted Oncology|February 28, 2024
Durvalumab Plus Gemcitabine and Cisplatin in Patients with Advanced Biliary Tract Cancer: An Exploratory Analysis of Real-World DataAlexander Olkus, Aurelie Tomczak, Anne Katrin Berger, et al.
Radiation Oncology (London, England)|February 19, 2025
Stereotactic body radiotherapy with carbon ions as local ablative treatment in patients with primary liver cancerPaula Hoffmeister-Wittmann, Philipp Hoegen-Saßmannshausen, Livia Wicklein, et al.
Cell Stem Cell|May 14, 2019
Single-Cell Analysis of the Liver Epithelium Reveals Dynamic Heterogeneity and an Essential Role for YAP in Homeostasis and RegenerationBrian J Pepe-Mooney, Michael T Dill, Anna Alemany, et al.
Pageof 5